BMS and Boryung to extend distribution agreement for 5 more years.

BMS Korea and Boryung agreed on Nov. 5 that the exclusive distribution agreement for BMS's 10 licensed products including Duricef Cap, an antibiotic originally effected from Oct. 1998 for 5 years would extend 5 more years until Oct. 2007.

Now, Boryung has a full antibiotic product line ranged from the lst generation, Duricef to the 4th as Maxpim whereas BMS Korea will concentrate their busin...